23 May 2007 |
New Agreement Boosts Pipeline for Synosia Therapeutics
|
23 May 2007 |
Abbott Announces Positive Nine-Month Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
|
23 May 2007 |
Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Ziprasidone HCl Capsules
|
22 May 2007 |
Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet
|
22 May 2007 |
Nektar Therapeutics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
|
22 May 2007 |
Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
|
22 May 2007 |
Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
|
22 May 2007 |
Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
|
22 May 2007 |
Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
|
21 May 2007 |
Sun Pharmaceutical Industries Agrees to Acquire Taro Pharmaceutical Industries in Transaction Valued at $454 Million
|
19 May 2007 |
KV Pharmaceutical Company (KVA) Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
|
18 May 2007 |
Roche and Siena Biotech S.p.A. Enter Research Collaboration Agreement in Neurodegenerative Diseases
|
17 May 2007 |
Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1
|
17 May 2007 |
Organon and Medarex announce biotherapeutics development agreement
|
17 May 2007 |
Glenmark receives US FDA approval to market generic
|
17 May 2007 |
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
|
17 May 2007 |
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
|
16 May 2007 |
Proteros Biostructures and Boehringer Ingelheim Pharmaceuticals Enter into Protein Crystallography Agreement
|
16 May 2007 |
Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Simvastatin Tablets
|
15 May 2007 |
Skyepharma PLC and Sciele Pharma Announce Successful Completion of New Sular(R) Formulation Clinical Trial Programme
|
15 May 2007 |
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl
|
15 May 2007 |
GSK Returns Development Rights for MED2002
|
13 May 2007 |
Mylan Laboratories to Acquire Generics Business of Merck KGaA
|
12 May 2007 |
DermTech and UCSF Collaborate to Explore Potential of Company's EGIR Technology to Develop Novel Compounds for Anti-aging and Atopic Dermatitis
|
11 May 2007 |
FDA Approves Schwarz Pharma's Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
|